1.28 million Australians are at a high risk of developing an osteoporotic fracture, and 80% of patients go undiagnosed – even after a fracture. That’s why we partnered with Amgen to raise awareness of this silent disease and encourage the most at-risk demographic (women over 50) to get tested, aiming to double to the diagnosis of osteoporosis by 2022.

And its success has been far-reaching, which is why we’re thrilled The Big O has recently been recognised with two prestigious 'Effie' effectiveness awards: Positive Change and Health & Wellbeing.  

‍